A Trial of CXD101 in Combination With Nivolumab in Patients With Metastatic Microsatellite-Stable Colorectal Cancer
Clinical trial NCT03993626 · UNKNOWN
Trial details
- NCT number
- NCT03993626
- Sponsor
- Celleron Therapeutics Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-22
- Primary completion
- 2019-12-15
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.